Myotonia clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for

  • Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

    Sorry, accepting new patients by invitation only

    A Global Phase 3 Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Intravenous Delpacibart Etedesiran (abbreviated del-desiran, formerly AOC 1001) for the Treatment of Myotonic Dystrophy Type 1

    Los Angeles 5368361, California 5332921 and other locations

Our lead scientists for Myotonia research studies include .

Last updated: